Nuformix plc (LON: NFX)
London
· Delayed Price · Currency is GBP · Price in GBX
0.0470
-0.0005 (-1.05%)
Nov 22, 2024, 2:38 PM BST
Nuformix Statistics
Total Valuation
Nuformix has a market cap or net worth of GBP 385,075. The enterprise value is 201,555.
Market Cap | 385,075 |
Enterprise Value | 201,555 |
Important Dates
The next estimated earnings date is Monday, December 30, 2024.
Earnings Date | Dec 30, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Nuformix has 819.31 million shares outstanding. The number of shares has increased by 8.94% in one year.
Current Share Class | n/a |
Shares Outstanding | 819.31M |
Shares Change (YoY) | +8.94% |
Shares Change (QoQ) | +6.72% |
Owned by Insiders (%) | 11.41% |
Owned by Institutions (%) | 45.99% |
Float | 723.88M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.09 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.42 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12
Current Ratio | 1.12 |
Quick Ratio | 1.12 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -159,295 |
Employee Count | 3 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.62% in the last 52 weeks. The beta is 1.22, so Nuformix's price volatility has been higher than the market average.
Beta (5Y) | 1.22 |
52-Week Price Change | -83.62% |
50-Day Moving Average | 0.06 |
200-Day Moving Average | 0.16 |
Relative Strength Index (RSI) | 32.96 |
Average Volume (20 Days) | 19,652,288 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -523,555 |
Pretax Income | -523,555 |
Net Income | -477,885 |
EBITDA | -496,705 |
EBIT | -523,555 |
Earnings Per Share (EPS) | -0.00 |
Balance Sheet
Cash & Cash Equivalents | 183,522 |
Total Debt | n/a |
Net Cash | 183,522 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 4.10M |
Book Value Per Share | 0.01 |
Working Capital | 29,281 |
Cash Flow
Operating Cash Flow | -471,354 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Nuformix does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.94% |
Shareholder Yield | -8.94% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |